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This study aimed at evaluating the neurotoxicity of fentanyl
analogs: (±)-cis-3-carbomethoxy fentanyl (C) and (±)-trans-3-
carbomethoxy fentanyl (T) in rats. C and T are less potent (2.4-3.1 and
8.4-12.3 times, respectively) than fentanyl (F) in producing both
antinociception and morphine-like neurotoxic effects: loss of pinna
reflex, Straub tail, impairment of motor coordination, catalepsy, loss of
corneal reflex and loss of righting reflex. All of the effects tested were
dose-dependent and they were abolished by pretreatment with
naloxone, nonselective antagonist of opioid receptors, indicating that
they are mediated via opioid receptors. Further, F, C and T exhibited
similar relative potencies in producing all tested effects, indicating that
similar receptors are involved in producing antinociceptive and
neurotoxic effects, most probably of  type. By using equi-
antinociceptive doses, C and T produced significantly shorter duration
of both antinociception and neurotoxicity than F. No significant
differences between therapeutic indices for F, C and T were found,
indicating that these compounds are equally safe and tolerable in
respect to the neurotoxic effects tested. Neurotoxicity testing presented
in this paper may be useful in studying the structure-activity relationship
of opioid congeners.
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INTRODUCTION
Fentanyl (Fig. 1A) belongs to 4-anilidopiperidine class of synthetic opioid
analgesics (Janssen et al., 1996). It is a strong opioid analgesic with widespread
use in the treatment of moderate to severe pain. However, the clinical use of the
fentanyl is limited by serious central nervous system side effects such as
respiratory depression, sedation, nausea, muscle rigidity, and after prolonged
use, tolerance and addiction (Geppetti and Benemei, 2009). Like morphine and
most other currently available strong opioid analgesics, fentanyl exerts analgesic
and adverse effects primarily through the opioid  receptors (Schumacher et al.,
2007).
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The most common approach in searching for novel drugs is structural
modification of the well known compounds (Mi}ovi} et al., 2000; Ivanovi} et al.,
2004a; Ivanovi} et al., 2004b; Vu~kovi} et al., 2009). Among the important
properties of the opioids that can be altered by structural modification are their
affinities for various types of opioid receptors, activities as agonists versus
antagonists, lipid solubilities, and their susceptibility/resistance to metabolic
breakdown (Feldman et al., 1991; Scholz et al., 1996; Ananthan, 2006).
Carfentanil (Fig. 1B) is 20-30 times more potent than fentanyl and is used in
veterinary medicine for immobilization of wild animals (Van Daele, 1976; De Vos,
1978). In previous work (Mi}ovi} et al., 1998; Vu~kovi} et al., 2000), the
regioisomer of carfentanyl, 3-carbomethoxy fentanyl (Fig. 1C and 1D), or "iso-
carfentanil" was prepared and tested for analgesic activity in rats. It was found that
(±)-cis-3-carbomethoxy fentanyl (Fig. 1C) and (±)-trans-3-carbomethoxy fentanyl
(Fig. 1D) were about 2 and 10 times less potent than fentanyl, respectively, but
their tolerability and safety compared with fentanyl remained unexplored. This
study is aimed at evaluating the relative tolerability and safety of (±)-cis and (±)-
trans-3-carbomethoxy fentanyl, by using tests for assesing morphine-like
neurotoxicity in rats, such as loss of pinna reflex, impairment of motor
coordination, Straub tail (tail in an erect position), catalepsy (muscular rigidity and
immobility), loss of corneal reflex and loss of righting reflex. In addition, in regard
to the neurotoxic effects, structure-activity relationship (SAR) of (±)-cis and (±)-
trans-3-carbomethoxy fentanyl was to be established.
MATERIALS AND METHODS
Animals
Male Wistar rats (200–250 g) obtained from Military Farm (Belgrade, Serbia)
were used. All experiments were approved by the Institutional Animal Ethics
Committee which operates in accordance with Revised Guide for the Care and
Use of Laboratory Animals (NIH Guide, Volume 25, Number 28, 1996). The
animals were housed in groups of 4 in plexiglass cages (36.5 x 21 x 14 cm) under
standard conditions: temperature of 22oC ± 1oC, and a 12/12 h light/dark cycle
with lights on at 08.00 h. Food pallets and tap water were available ad libitum,
except during the experimental procedure. Prior to each experiment the animals
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Figure 1. Fentanyl (A), carfentanil (B), (±)-cis-3-carbomethoxy
fentanyl (C) and
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were habituated to handling and experimental procedures for at least three
consecutive days. Experiments were done in a sound–proofed, diffusely
illuminated room maintained at a temperature of 22±1oC. They were performed at
the same time of the day between 9:00 and 13:00 h to avoid diurnal variation in
behavioral tests. The animals were unrestrained during all experimental
procedures, except antinociception testing. Experimental groups consisted of
6–8 rats. Each animal was tested only once and was killed with an intraperitoneal
injection of sodium thiopental.
Antinociception testing
In the first set of experiments, antinociceptive activity was determined by tail-
immersion test (Janssen et al., 1963). In brief, the rat was placed in a
hemicylindrical plexiglass cage with its tail hanging freely outside the cage. The
distal 5 cm of the tail was immersed in a warm water bath (55±0.5oC) and the time
for tail-withdrawal was measured as a response latency. In order to minimize
tissue damage by repeated testing, a cut-off time of 6 s was adopted. This means
that the maximal duration of a single exposure of rat tail to hot water was 6 sec.
Predrug response latency was obtained 5 min before i.p. drug (or saline solution
in the control group) administration. Postdrug response latency was measured
after intraperitoneal (i.p.) administration of test compound (or saline solution in the
control group) at 5, 10, 15, 20, 40, 60, 90 etc. min. The data are expressed
quantally as the number of animals in which the antinociception was observed
versus total number of animals receiving the same treatment. For antinociception,
the following criterion was used: an antinociceptive effect was said to have
occurred if postdrug response latency was  6s.
Neurotoxicity testing
In the second set of experiments, toxic effects were tested in the following
order: loss of pinna reflex, loss of corneal reflex, tail stiffness (Straub tail),
catalepsy, impairment of motor coordination and loss of righting reflex in each
single rat. Experimental groups consisted of 6–8 rats. The data are expressed
quantally as the number of animals in which the effect was observed versus total
number of animals receiving the same treatment.
Testing was performed once before and at 5, 20, 40, 60, 90 etc. min after i.p.
drug (or saline solution in the control group) injection by two observers unaware
of the pharmacological treatment. Tail stiffness ("Straub tail") was assessed by
observation, as well as touching the tail (Benthuysen et al., 1986). The pinna reflex
was tested by touching the pinna with a pencil tip. (Meert et al., 1988). The corneal
reflex was tested by touching the cornea with a small peace of cotton (Meert et al.,
1988). Catalepsy was defined as the failure of the animal to move within 60 s from
a position in which the forepaws and hind paws were placed on bars 10 cm from
the floor (Klemm, 1989; Vu~kovi} et al., 1998). The righting reflex was measured
by placing the animal onto its back and measuring how long it took to regain an
upright position. The righting reflex was considered absent when all four limbs
remained off the table surface for at least 30 s (Yang et al., 1992; Ivanovi} et al.,
1995). Impairment of motor coordination was defined as the inability of the rat to
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descend in a coordinated fashion a 60-degree-inclined wire mesh ramp (Yaksh et
al., 1986).
Drugs Administration
Fentanyl citrate (ICN Yugoslavia, Belgrade, Serbia) and (±)-cis and (±)-
trans-3-carbomethoxy fentanyl oxalate were dissolved in saline and injected
intraperitoneally at a final volume of 2 mL/kg. Both (±)-cis and (±)-trans-3-
carbomethoxy fentanyl (Faculty of Chemistry, University of Belgrade, Serbia) were
examined as a racemic mixture. Doses of the drugs were calculated for the free
base. Naloxone hydrochloride (Sigma Chemical Co. St. Louis, USA) was also
dissolved in saline, and injected subcutaneously (s.c., 1 mg/kg) in the back 10
min before the intraperitoneal (i.p.) injection of the test compound in the same
volume. In order to test whether saline injection has any effect on nociception or
toxic behavior, 2 mL/kg of saline were administrated i.p. in a control group of rats.
Statistical Analysis
To permit direct comparison of different compounds and different effects,
basic data for each animal were transformed to a quantal response (presence or
absence of expected drug effect). For each effect and each dose maximum
response obtained during time of measurement was used for evaluation. Then,
computations were done according to the methods of Tallarida and Murray
(1986).
RESULTS
Fentanyl (F; 0.0073-0.120 mg/kg; ip), ()cis 3-carbomethoxy fentanyl (C;
0.016-0.326 mg/kg; ip) and ()trans 3-carbomethoxy fentanyl (T; 0.08-1.22 mg/kg;
i.p) produced dose-dependent increase in antinociception, loss of pinna reflex,
impairment of motor coordination, Straub tail, catalepsy, loss of corneal reflex and
loss of righting reflex (Fig. 2). For each effect tested, probit slopes for F, C and T
are not significantly different (p>0.05, test for parallelism).
The median effective doses for antinociception (AD50) and toxic effects
(TD50), and the relative potencies for F, C and T are presented in Table 1. The
median effective doses (ED50) for C and T are significantly higher (p<0.05) in
comparison with the corresponding doses for F (Table 1), indicating that C and T
are less potent than F in producing antinociceptive and toxic effects. Also, T was
significantly less potent (p<0.05) in producing all observed effects compared with
C (Table 1). The potency ratios indicate that C (ED50=0.024 (0.017-0.034)) and T
(ED50=0.084 (0.054-0.131)) are less potent analgesics (2.4 and 8.4 times,
respectively), in comparison with F (ED50=0.010 (0.007-0.014)). In regard to toxic
effects, C and T are less potent (2.4-3.1 and 10.8-12.3 times, respectively) than F
(Table 1). T is 3.5 and 3.6-5.1 times less potent than C in inducing antinociception
and toxicity, respectively (not shown).
Each of tested compounds, exhibited similar (p>0.05) relative potencies in
producing all tested effects (95% confidence intervals overlap) (Table 1).
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Figure 2. Log dose-probit curves for antinociception (tail-immersion test) and toxic effects
for fentanyl (A), (±)-cis-3-carbomethoxy fentanyl (B) and (±)-trans-3-carbomethoxy
fentanyl (C) in rats. Doses of the compound tested are expressed in mg/kg. For each
effect and each dose, the percentage of rats that respond to treatment is transformed
to a probit value. Each point represents the results obtained from 6-8 rats
Table 1. Median effective doses (AD50 and TD50), correlation coefficient (r),
probit slopes and relative potencies with 95% confidence limits (95% CL) for
fentanyl, (±)-cis-3-carbomethoxy fentanyl and (±)-trans-3-carbomethoxy fentanyl
in inducing antinociception, loss of pinna reflex, motor impairement, Straub tail,
catalepsy, loss of corneal reflex, and loss of righting reflex in rats
Effect
AD50 or TD50
(95% CL) r
Probit slope
(95% CL)
Relative potency
(95% CL)
Fentanyl (0,0073-0,12 mg/kg)
Antinocicep.a
0.010
(0.007-0.014) 0.968
4.08
(-9.3-17.5) 1
Loss of pinna r.
0.025
(0.021-0.030) 0.981
13.1
(-20.1-46.4) 1
Motor impair.
0.036
(0.023-0.054) 1.000
3.8
(3.0-4.5) 1
Straub tail
0.043
(0.030-0.060) 0.957
3.8
(-10.1-18.6) 1
Catalepsyb
0.064
(0.054-0.074) 0.983
10.3
(-13.8-34.3) 1
Loss of corn. r.
0.071
(0.053-0.095) 0.871
5.4
(-33.3-44.1) 1
Loss of right. r.c
0.084
(0.068-0.100) 0.987
7.5
(-8.3-23.3) 1
(±)-cis-3-Carbomethoxy fentanyl (0.016-0.326 mg/kg)
Antinocicep.
0.024
(0.017-0.034) 0.977
4.6
(-8.1-17.3)
0.408*
(0.247-0.676)
Loss of pinna r.
0.061
(0.052-0.071) 0.999
15.6
(5.3-25.5)
0.412*
(0.328-0.518)
Motor impair.
0.099
(0.060-0.166) 0.962
2.7
(-6.9-12.3)
0.357*
(0.184-0.693)
Straub tail
0.125
(0.080-0.197) 0.995
5.0
(-1.6-11.6)
0.339*
(0.192-0.599)
Catalepsyb
0.189
(0.123-0.291) 0.988
3.1
(-3.0-9.3)
0.336*
(0.213-0.529)
Loss of corn. r.
0.208
(0.169-0.256) 0.969
6.4
(-14.3-26.9)
0.342*
(0.240-0.488)
Loss of right. rc
0.257
(0.217-0.303) 0.885
7.7
(-43. 8-59.2)
0.327*
(0.250-0.426)
(±)-trans-3-Carbomethoxy fentanyl (0.08-1.22 mg/kg)
Antinocicep.a
0.084
(0.054-0.131) 0.988
3.6
(-3.5-10.7)
0.117*
(0.066-0.209)
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Loss of pinna r.
0.308
(0.274-0.346) 0.924 11.6 (-49.3-72.4)
0.082*
(0.067-0.100)
Motor impair.
0.441
(0.389-0.499) 0.974 12.5 (-24.0-48.9)
0.081*
(0.052-0.125)
Straub tail
0.513
(0.404-0.651) 0.982 7.0 (-10.2-24.3)
0.083*
(0.055-0.126)
Catalepsyb
0.767
(0.587-1.003) 0.971 5.2 (-11.1-21.5)
0.083*
(0.061-0.113)
Loss of corn. r.
0.768
(0.587-1.006) 0.991 5.9 (-4.5-16.9)
0.093*
(0.062-0.138)
Loss of right. rc. 0.927(0.696-1.235) 0.970 4.6 (-10.1-19.2)
0.091*
(0.064-0.129)
AD50=median effective doses (ED50) in inducing antinociception. TD50 = median effective doses
(ED50) in inducing toxic effects. Median effective doses for each effect and each compound was
calculated by using 3 doses. One dose is tested in at least 6 rats (Litchfield & Wilcoxon I test). acriterion
6 s. bcriterion 60 s. ccriterion 30 s.
*Relative potency estimates were considered statistically significant when 95% CL did not overlap 1.0
(p<0.05, Litchfield & Wilcoxon II test).
When the doses of all three tested drugs were increased above their
antinociceptive doses, the toxic effects appeared in a similar order (Table 1, Fig.
2). Loss of pinna reflex occurred first, followed by impairment of motor
coordination and Straub tail. With further increases in doses, catalepsy, loss of
corneal reflex and loss of righting reflex occurred (Table 1, Fig. 2).
The therapeutic indices for all three compounds tested (calculated as
TD50/AD50) are shown in Table 2. The AD50 values for F, C, and T are significantly
lower (p<0.05) than their TD50 values (Table 2). Within each effect, there are no
significant differences (p>0.05) between TIs for F, C and T (Table 2).
Time course of the antinociceptive and toxic effects obtained with equi-
antinociceptive doses (4xED50, 8xED50 and 15xED50) of F, C and T is presented in
Fig. 3. By using equi-antinociceptive doses (4xED50 and 8xD50), C and T produced
significantly shorter duration of antinociception than F (p<0.01; Mann–Whitney U-
test). There is no difference in the duration of analgesia between C and T. Also, C
and T exhibited faster onset of analgesia in comparison with F. After i. p. injection
of 4xAD50 of C, T, and F, analgesia peaked at 5, 5 and 15 min, respectively (Figs. 3
A and B).
At doses 15xAD50, C and T produced significantly (p<0.05 or p<0.01;
Mann–Whitney U-test) shorter duration of loss of pinna reflex, impairment of motor
coordination, Straub tail, catalepsy, loss of corneal reflex, and loss of righting
reflex, than F (Figs. 3C-H, Table 2). There is no difference in the duration of toxic
effects between C and T. In the majority of the effects observed, C and T achieved
peak effect faster (at the first time point measurement, ie 5 min) than F (at the
second time point measurement, ie 20 min) (Figs. 3C-H).
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cont. Table 1.
Table 2. Therapeutic indices (TI) with 95% confidence limits (95% CL) and duration
of toxic effects (loss of pinna reflex, motor impairement, Straub tail, catalepsy, loss
of corneal reflex, loss of righting reflex) for fentanyl, (±)-cis-3-carbomethoxy fentanyl
and (±)-trans-3-carbomethoxy fentanyl in rats
Drug tested Fentanyl
(±)-cis-3-
Carbomethoxy
fentanyl
(±)-trans-3-
Carbomethoxy
fentanyl
Effects
Therapeutic
index
(95% CL)
Duration
(min)a
Therapeutic
index
(95% CL)
Duration
(min)a
Therapeutic
index
(95% CL)
Duration
(min)a
Loss of pinna r.
2.56 *
(1.71-3.83) 120
2.53*
(1.73-3.70) 60
+ 3.68*
(2.32-5.83) 40
+
Motor impair.
3.61*
(2.07-6.31) 90
4.12*
(2.23-7.65) 40
+ 5.27*
(3.31-8.37) 40
+
Straub tail
4.33*
(2.62-7.15) 60
5.20*
(2.94-9.20) 20
+ 6.13*
(3.69-10.16) 40
+
Catalepsy
6.47*
(4.34-9.63) 60
7.87*
(4.54-13.64) 20
+ 9.16*
(5.44-15.41) 20
Loss of corneal r.
7.26*
(4.55-11.57) 60
8.65*
(5.79-12.93) 40
+ 9.18*
(5.45-15.46) 20
+
Loss of righting r.
8.54*
(5.60-13.02) 60
10.67*
(7.27-15.65) 20
+ 11.07*
(6.51-18.82) 5
+
Therapeutic index (TI) is calculated as TD50/AD50 potency ratio for each drug *p<0.05, Litchfield &
Wilcoxon II test. If 95% CL for a TI fails to include 1.0, then TD50 and AD50 are significantly different.aDuration of action after i.p. injection of equi-analgesic doses of 15 x AD50 by using a criteria >50% of
rats responding + p<0.05 indicates a significant shorter duration of action of fentanyl analog in
comparison to fentanyl (Mann–Whitney U-test)
Naloxon hydrochloride (1 mg/kg; sc) given 10 min before ip injection of
8xED50 and 15xED50 of F, C and T abolished antinociceptive and toxic effects (not
shown).
Ip injection of saline (0.2 mL/kg) had no effect on the animal's behavior, as
well as tail immersion latency (p>0.05); the latencies before and after saline
injection were found to be 2.32 ± 0.32 and 2.40 ± 0.25 s, respectively (n = 8) (not
shown).
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Figure 3. Time-effect curve for the antinociceptive and toxic effects of fentanyl (circle), (±)-
cis-3-carbomethoxy fentanyl (quadrant) and (±)-trans-3-carbomethoxy fentanyl
(triangle) in rats. The incidence of antinociception (A and B), loss of pinna reflex (C),
impairment of motor coordination (D), Straub tail (E), catalepsy (F), loss of corneal
reflex (G), and loss of righting reflex (H) are plotted as a function of time after i.p.
injection of 4xAD50 (white symbols), 8xAD50 (gray symbols) and 15xAD50 (black
symbols) for of fentanyl, (±)-cis-3-carbomethoxy fentanyl and (±)-trans-3-
carbomethoxy fentanyl. Each dose was tested by using 6-8 rats. Each point
represents the percentage of rats ± S.E. that respond to the treatment. *p<0.05 and
**p<0.01 indicate a significant difference of the responses of (±)-cis-3-
carbomethoxy fentanyl in comparison to fentanyl (Mann-Whitney – U test). #p<0.05
and ##p<0.01 indicate a significant difference of the responses of (±)-trans-3-
carbomethoxy fentanyl in comparison to fentanyl (Mann-Whitney -U test)
DISCUSSION
In the present experiments all three compounds tested: fentanyl (F), (±)cis
3-carbomethoxy fentanyl (C) and (±)trans 3-carbomethoxy fentanyl (T),
produced a dose-dependent increase in antinociception and morphine-like
effects, such as loss of the pinna reflex, Straub tail, impairment of motor
coordination, catalepsy, loss of corneal reflex and loss of righting reflex. This
finding is in agreement with previous reports on actions of fentanyl in rats (Meert et
al., 1988; Ivanovi} et al., 1995; Vu~kovi} et al., 1998; Vu~kovi} et al., 2000). C and T
are less potent (2.4-3.1 and 8.4-12.3 times, respectively) than fentanyl (F) in
producing both the antinociception and neurotoxicity. The antinociceptive and
toxic effects of F, C and T were abolished by pretreatment with naloxone, which is
a nonselective antagonist of opioid receptors, indicating that toxic effects are
mediated by opioid receptors. It was revealed that F, C and T exhibited similar
relative potencies in producing all tested effects. If a series of related agonists
exhibits identical relative potencies in producing distinct effects, it is likely that
these effects are mediated by similar or identical receptor molecules (Bourne and
Zastrow, 2007). In the case of F, C and T, they are most probably of the  type. This
is consistent with previous reports that  opioid receptors are involved in the
mechanisms of opioid induced antinociception, Straub tail, muscle rigidity,
catalepsy and other morphine-like behavioural effects in rats (Negri et al., 1992;
Nath et al., 1994; Chen et al., 1996; Piepponen et al., 1997).
Most of the currently available opioid analgesics exert their analgesic and
adverse effects primarily through the opioid  receptors. However, individual
strong opioids may interact, at least in part, with different opioid receptor
subpopulations or modulate  opioid receptor signaling in different ways
(Pasternak, 2004; Lee et al., 2007), that may improve tolerability (Ananthan, 2006;
Smith, 2008; Spetea et al., 2010).
There are no significant differences between therapeutic indices for F, C and
T, which means that these compounds are equally tolerable in regard to the
observed neurotoxic effects, and the difference between them is in the potency
and the time course of action.
By using equi-antinociceptive doses, C and T produced significantly shorter
duration of both, antinociception and neurotoxicity, than F. Also, there is no
difference in the duration of effects between C and T. One of the possible
explanation for the shorter duration of action of 3-carbomethoxy fentanyl in
comparison with fentanyl might be the susceptibility of the carbomethoxy group
to rapid hydrolysis by non-specific esterases (Feldman et al., 1991). It is possible,
also that the introduction of 3-carbomethoxy group in the piperidine ring affects
duration of action by altering physicochemical properties (Scholz et al., 1996).
SUMMARY
In summary, (±)cis 3-carbomethoxy fentanyl and (±)trans 3-carbomethoxy
fentanyl are less potent (2.4-3.1 and 8.4-12.3 times, respectively) than fentanyl in
producing both antinociception and neurotoxicity in rats. All three compounds are
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equally tolerable and safe drugs in respect to neurotoxic effects. Also, F, C and T
exhibited similar relative potencies in producing all evaluated effects, and the
structure-activity relationship on neurotoxic effects of fentanyl analogs obtained
by introducing carbomethoxy group in the position 3 of the piperidine ring,
parallels the structure-activity relationship on antinociception. All of these taken
together, might suggest that similar receptors are involved in producing both
antinociceptive and neurotoxic effects of F, C and T, most probably of  type.
Animal testing presented in this paper consists of procedures which can be
performed easily and in parallel manner providing several useful pharmacological
informations regarding efficacy, potency, time course of action, safety and
tolerability, and also, could be indicative whether the observed drug effects are
mediated by similar or different receptors. Therefore, we recommend it as a useful
approach in studying the structure-activity relationship of opioid congeners.
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ISPITIVANJE NEUROTOKSI^NOSTI ANALOGA FENTANILA KOD PACOVA
VU^KOVI] SONJA, SAVI] VUJOVI] KATARINA, IVANOVI] M, DO[EN-MI]OVI]
LJILJANA, TODOROVI] Z, VU^ETI] ^, PROSTRAN M i PROSTRAN MILICA
SADR@AJ
Cilj studije bio je da se ispita neurotoksi~nost analoga fentanila: (±)-cis-3-
karbometoksi fentanila (C) i (±)-trans-3-karbometoksi fentanil (T) kod pacova. C
je oko 2,4-3,1, a T oko 8,4-12,3 puta manje potentan od fentanila u izazivanju
antinocicepcije i morfinu-sli~nih neurotoksi~nih efekata u koje spadaju: refleks
u{ne {koljke, Straub-ov rep, poreme}aj motorne koordinacije, katalepsija, gubi-
tak kornealnog refleksa i gubitak refleksa uspravljanja. Svi ispitivani efekti su
dozno-zavisni i bivaju poni{teni ako se u pretretmanu primeni nalokson, neselek-
tivni antagonist opioidnih receptora, {to ukazuje da se efekti odigravaju pos-
redstvom opioidnih receptora. Dalje, F, C i T ispoljavaju sli~nu relativnu ja~inu u
izazivanju ispitivanih efekata, {to ukazuje da su sli~ni receptori uklju~eni u meha-
nizam antinocicepcije i neurotoksi~nih efekata, i to su najverovatnije  receptori.
Kad se primenjuju ekviantinociceptivne doze, C i T izazivaju zna~ajno kra}e i
antinociceptivno i neurotoksi~no dejstvo od F. Nisu dokazane zna~ajne razlike u
terapijskim indeksima izme|u F, C i T, {to ukazuje da su ovi lekovi jednako
bezbedni i podno{ljivi kad su u pitanju ispitivani neurotoksi~ni efekti. Ispitivanje
neurotoksi~nosti prikazano u ovom radu mo`e biti korisno u prou~avanju odnosa
izme|u strukture i aktivnosti hemijski srodnih opioida.
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